Lipum (publ), a clinical stage biopharmaceutical company focused on chronic inflammatory diseases, today announced its participation in the following upcoming events.
BIO-Europe Spring | March 20–22, 2023 | Basel, Switzerland
LSX World Congress | May 3-4, 2023 | London, UK
Redeye Investor Forum | May 11, 2023 | Malmö, Sweden
BioStock Life Science Summit Spring | May 30-31, 2023 | Digital
BIO International Convention | June 5-8, 2023 | Boston, MA, USA
“Our phase 1 clinical study on the lead candidate SOL-116 is ongoing and industry meetings provide opportunities to maintain our contacts and present the progress”, says CEO Einar Pontén.